Your browser doesn't support javascript.
loading
Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
Winter, Amy K; Lambert, Brian; Klein, Daniel; Klepac, Petra; Papadopoulos, Timos; Truelove, Shaun; Burgess, Colleen; Santos, Heather; Knapp, Jennifer K; Reef, Susan E; Kayembe, Lidia K; Shendale, Stephanie; Kretsinger, Katrina; Lessler, Justin; Vynnycky, Emilia; McCarthy, Kevin; Ferrari, Matthew; Jit, Mark.
Afiliación
  • Winter AK; Department of Epidemiology and Biostatics and Center for the Ecology of Infectious Diseases, University of Georgia, Athens, GA, USA. Electronic address: awinter@uga.edu.
  • Lambert B; Department of Biology, Pennsylvania State University, State College, PA, USA.
  • Klein D; Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Klepac P; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
  • Papadopoulos T; Department of Statistics Modelling and Economics, UK Health Security Agency, London, UK; Institute of Sound and Vibration Research, University of Southampton, Southampton, UK.
  • Truelove S; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Burgess C; Ramboll Health Sciences, Copenhagen, Denmark.
  • Santos H; Department of Biology, Pennsylvania State University, State College, PA, USA.
  • Knapp JK; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Reef SE; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Kayembe LK; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Shendale S; Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • Kretsinger K; Department of Immunization, Vaccines and Biologicals, WHO, Geneva, Switzerland.
  • Lessler J; Department of Epidemiology, Gillings School of Global Public Health and Carolina Population Center, University of North Carolina, Chapel Hill, NC, USA.
  • Vynnycky E; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK; Depa
  • McCarthy K; Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, WA, USA.
  • Ferrari M; Department of Biology, Pennsylvania State University, State College, PA, USA.
  • Jit M; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.
Lancet Glob Health ; 10(10): e1412-e1422, 2022 10.
Article en En | MEDLINE | ID: mdl-36113527
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Sarampión Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Rubéola (Sarampión Alemán) / Sarampión Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Lancet Glob Health Año: 2022 Tipo del documento: Article